ArticleMicrobial genomics2025
ANASFV: a workflow for African swine fever virus whole-genome analysis.
Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Live-Attenuated Vaccines Against African Swine Fever: Strategies, Lessons, and Prospects.Biology · 2026Review
- Establishment of a Tetra-Primer ARMS-PCR Assay to Discriminate Genotypes I and II African Swine Fever Viruses.Transboundary and emerging diseases · 2026Article
- African swine fever control in the context of endemic persistence.Frontiers in veterinary science · 2026Article
- 'PePApipe': A complete bioinformatics analysis pipeline for African Swine Fever Virus genome.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
African swine fever virus (ASFV) is highly transmissible and can cause up to 100% mortality in pigs. The virus has spread across most regions of Asia and Europe, resulting in the deaths of millions of pigs. A deep understanding of the genetic diversity and evolutionary dynamics of ASFV is necessary to effectively manage outbreaks. Genetic analysis of the ASFV requires sequencing and assembling its genome. Nanopore sequencing is increasingly used for ASFV analysis due to advantages such as long reads and portability. However, applying nanopore sequencing to ASFV genomes faces challenges, notably a higher error rate. Additionally, there is a lack of standardized methods for evaluating genome quality. Furthermore, an increasing number of recombinant isolates between genotypes I and II have been observed, complicating phylogenetic analysis. To overcome these obstacles, we developed ANASFV (analysis of an ASFV whole genome), a comprehensive pipeline that accomplishes four main tasks. First, the pipeline introduces an amplicon sequencing approach that significantly improves genomic coverage, enabling reliable genome assembly, and employs reference-aided polishing techniques to correct small indels caused by nanopore sequencing errors. Second, it establishes a system to provide a relative reference for assessing genome quality in terms of both completeness and accuracy of the assembled genomes. We found that almost all ASFV genomes based solely on nanopore sequencing in the NCBI were of poor quality, which improved significantly after reference-aided polishing. Third, the pipeline introduces a method to rapidly analyse whether an isolate is a recombinant between genotypes I and II, as well as to determine the pattern of recombination based on gene similarity. We identified 11 recombinant ASFV genotypes I and II in the NCBI. Lastly, a comprehensive phylogenetic analysis based on coding sequences was conducted, allowing researchers to generate a refined phylogenetic tree that includes all known ASFV genomes. The ANASFV pipeline facilitates ASFV whole-genome sequencing using the nanopore platform and supports robust downstream bioinformatic analyses by assessing gene completeness and conducting detailed phylogenetic studies based on whole-genome data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.